There were 1,513 press releases posted in the last 24 hours and 454,358 in the last 365 days.

Scientists Recognize Link Between Herpes Virus and Alzheimer’s Disease

31 specialists pen an editorial in the Journal of Alzheimer’s Disease.

We are saying there is incontrovertible evidence that Alzheimer’s Disease has a dormant microbial component. We can’t keep ignoring all of the evidence.
— Professor Douglas Kell
ROCHESTER, NEW YORK, UNITED STATES OF AMERICA, April 18, 2016 /EINPresswire.com/ --

“Infected with the herpes simplex virus (HSV-1 or HSV-2)? The CBCD recommends taking Gene-Eden-VIR or Novirin against the latent virus.” – Greg Bennett, CBCD

The oral herpes virus may cause Alzheimer’s Disease, according to a worldwide team of senior scientists. This group is comprised of 31 specialists from Oxford, Edinburgh, Manchester, and Cambridge universities, as well as Imperial College, wrote an editorial that suggested herpes (and other pathogens) as a cause of Alzheimer’s Disease. (1) The authors of the editorial named three main candidates for the cause of the disease. These included the herpes simplex virus 1 (HSV-1), a type of corkscrew-shaped bacteria called spirochaete, and the chlamydia bacteria. (1) The editorial was published in the Journal of Alzheimer’s Disease.

“We are saying there is incontrovertible evidence that Alzheimer’s Disease has a dormant microbial component. We can’t keep ignoring all of the evidence.” - Professor Douglas Kell of the University of Manchester’s School of Chemistry (1)

Click to learn more about herpes symptoms.

“The authors say that viruses and bacteria are common in the brains of elderly people, and although they are usually dormant, they can ‘wake up’ after stress or if the immune system is compromised. Around two thirds of people will acquire the herpes virus at some point in their lives, and many will not realise they have it.” (1) The Center for the Biology of Chronic Disease (CBCD) recommends that individuals who have ever had a cold sore (and therefore are infected with HSV), take Gene-Eden-VIR against the latent herpes virus.

The formula of Novirin and Gene-Eden-VIR was tested by Hanan Polansky and Edan Itzkovitz from the CBCD. The studies showed that the Novirin and Gene-Eden-VIR formula is effective against the herpes simplex virus, and other viruses. The clinical studies were published in the peer reviewed, medical journal Pharmacology & Pharmacy, the first, in a special edition on Advances in Antiviral Drugs. Study authors wrote that, "individuals infected with the HSV … reported a safe decrease in their symptoms following treatment with Gene-Eden-VIR." (2) The study authors also wrote that, "we observed a statistically significant decrease in the severity, duration, and frequency of symptoms." (2)

Both products can be ordered online on the Novirin and Gene-Eden-VIR websites, here:

http://www.gene-eden-vir.com

and

http://www.novirin.com

Novirin and Gene-Eden-VIR are natural antiviral dietary supplements. Their formula contains five natural ingredients: Selenium, Camellia Sinesis Extract, Quercetin, Cinnamomum Extract, and Licorice Extract. The first ingredient is a trace element, and the other four are plant extracts. Each ingredient and its dose was chosen through a scientific approach. Scientists at polyDNA, the company that invented and patented the formula, scanned thousands of scientific and medical papers published in various medical and scientific journals, and identified the safest and most effective natural ingredients against latent viruses.

To date, Novirin and Gene-Eden-VIR are the only natural antiviral products on the market with published clinical studies that support their claims.

“The herpes virus in particular is known to damage the central nervous system, and the limbic system in the brain which regulates mood and instinct and is associated with mental decline and personality changes. They also point to the fact that a gene mutation - APOEe4 - which makes one in five people more susceptible to Alzheimer’s disease, also raises their susceptibility to infectious disease. Viral infections in the brain are already known to cause symptoms similar to Alzheimer’s and the experts say the link has been ‘neglected’ for too long.” (1)

What treatments are available for herpes infections?

“Two types of antiviral treatments against HSV are available: topical and oral. The treatments include penciclovir, acyclovir, famciclovir, and valaciclovir. However, their effectiveness is limited. For instance, a meta-analysis of five placebo-controlled and two dose comparison studies evaluated the effect of aciclovir, famciclovir or valaciclovir on symptoms. The meta-analysis showed that oral antiviral therapy decreases the duration and the associated pain of an outbreak by merely one day.” (2) There are also the natural supplements Novirin and Gene-Eden-VIR, which have a formula that was designed to help the immune system target the herpes virus when it is in a latent form.

The CBCD reminds the public that Gene-Eden-VIR and Novirin are not a cure. However, two clinical studies, published in peer reviewed medical journals showed that their formula decreases symptoms in infected individuals. Specifically, the formula of Gene-Eden-VIR and Novirin was shown to safely and effectively reduce herpes symptoms. Additionally, it was designed to help the immune system target the latent virus.

“We recommend that individuals who are infected with a latent herpes virus, take Gene-Eden-VIR or Novirin.” – Greg Bennett, CBCD

Find us on Facebook here: https://www.facebook.com/GeneEdenVIR
Follow us Twitter here: @HananPolansky

All orders of these products are completely confidential, and no information is shared or sold to any third party. Privacy is assured.

References:

(1) The Telegraph
Sarah Knapton - http://www.telegraph.co.uk/news/science/science-news/12188092/Alzheimers-disease-could-be-caused-by-herpes-virus-warn-experts.html

(2) Polansky, H. Itzkovitz, E. Gene-Eden-VIR Is Antiviral: Results of a Post Marketing Clinical Study. Published in September 2013.http://www.scirp.org/journal/PaperInformation.aspx?PaperID=36101#.VCvd5GeSz90

Greg Bennett
CBCD
585-250-9999
email us here

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.